End Stage Renal Disease Esrd Drug Market Size And Share

  • Report Code : TIPRE00016858
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Análisis de la cuota de mercado y oportunidades de medicamentos para la enfermedad renal en etapa terminal (ESRD) 2025-2031

Buy Now

End Stage Renal Disease (ESRD) Drug Market Report End Stage Renal Disease (ESRD) Drug Market Scope and Analysis End Stage Renal Disease (ESRD) Drug Market Size and Share

End Stage Renal Disease (ESRD) Drug Market Report Analysis

End Stage Renal Disease (ESRD) Drug Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • AbbVie Inc.
  • Amgen
  • AstraZeneca
  • Sanofi
  • Kyowa Kirin Co., Ltd.
  • Takeda Pharmaceutical Company Limited
  • Astellas Pharma Inc.
  • Bayer AG
  • Vifor Pharma Management Ltd.

Regional Overview

  • América del Norte
  • Europa
  • Asia-Pacífico
  • América del Sur y Central
  • Medio Oriente y África

Market Segmentation

By Tipo de producto
  • calcimiméticos
  • vitamina D
  • esteroles
  • quelantes de potasio
  • quelantes de fosfato a base de calcio
  • otros
By Indicación
  • hiperparatiroidismo inducido por enfermedad renal en etapa terminal
By Canal de Distribución
  • Farmacias Hospitalarias
  • Farmacias Online
  • Farmacias Minoristas
By Geografía
  • América del Norte
  • Europa
  • Asia-Pacífico
  • América del Sur y Central